Therapy News and Research

RSS

Monoclonal Antibodies: Discovery, Characterization and Challenges

In this interview, News-Medical talks to David Apiyo, a senior manager of applications at Sartorius AG, about monoclonal antibody development and characterization.

22 Oct 2020

Tumor DNA in spinal fluid can help track children with aggressive brain tumors

For many cancers, doctors are increasingly looking to the DNA that solid tumors shed into the blood stream to help with diagnosis and monitoring. But brain cancer has been a different story thanks to the natural blockade created by the blood-brain barrier.

22 Oct 2020

Newly developed light-sensing protein restores vision in blind mice

A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when attached to retina bipolar cells using gene therapy.

22 Oct 2020

Study: Antibody-based drug could dramatically reduce cancer in mice

Despite the remarkable successes of immune-based treatments for cancer, not everyone responds to these approaches and relapses do occur.

22 Oct 2020

Studies examine impact of COVID-19 on neonatal intensive care units

Two studies examining the impact of COVID-19 on neonatal intensive care units (NICUs) found the prevalence of COVID-19 in NICU infants is low, yet many hospitals at the start of the pandemic put in place strict parental visitation policies and scaled back NICU services such as lactation support and therapy.

22 Oct 2020

Ancient elements in human DNA can activate powerful immune response to kill cancer cells

Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.

22 Oct 2020

Tryptophan found in turkeys can accelerate intestinal healing in people with celiac disease

People with celiac disease may find themselves more comfortable with extra Thanksgiving turkey dinners.An international team of researchers led by McMaster University has found that tryptophan, an amino acid present in high amounts in turkey, along with some probiotics, may help them heal and respond better to a gluten-free diet.

22 Oct 2020

Moffitt researchers find immune-oncologic differences in prostate tumors of African American men

Prostate cancer is the most common type of cancer among American men after skin cancer, but the disease does not affect all races equally.

21 Oct 2020

Scientists develop a way to accurately detect and monitor common pediatric brain cancer

A team of scientists at Texas A&M University, Baylor College of Medicine and Texas Children's Hospital have developed a way to more accurately both detect and monitor a common type of pediatric brain cancer, setting the stage for giving clinicians a real-time view into how the cancer responds to treatment.

21 Oct 2020

Research shows the value of Multi-User Virtual Reality remote psychotherapy for eating disorders

Research from the University of Kent, the Research center on Interactive Media, Smart systems and Emerging technologies - RISE Ltd and the University of Cyprus has revealed that Virtual Reality technology can have significant impact on the validity of remote health appointments for those with eating disorders, through a process called Virtual Reality Exposure Therapy.

21 Oct 2020

Study characterizes biochemical mechanism of cancer-linked enzyme

A new study led by scientists at IUPUI and Indiana University Bloomington is the first to describe a biochemical mechanism that increases the activity of a molecule whose presence is observed in many types of cancer.

21 Oct 2020

Researchers receive more than $1 million NIH grants for COVID-19 pandemic-related projects

Researchers in Northern Arizona University's Center for Health Equity Research and the Southwest Health Equity Research Collaborative recently received four grants totaling more than $1 million from the National Institutes of Health for projects related to the COVID-19 pandemic.

21 Oct 2020

New DNA-cutting tool could advance gene editing for novel treatments

Gene editing for the development of new treatments, and for studying disease as well as normal function in humans and other organisms, may advance more quickly with a new tool for cutting larger pieces of DNA out of a cell's genome, according to a new study by UC San Francisco scientists.

21 Oct 2020

NIH awards $1.6 million for research on hormonal control of HIV latency

The National Institutes of Health has awarded $1.6 million to researchers at the George Washington University School of Medicine and Health Sciences for research on hormonal control of HIV latency.

20 Oct 2020

UC study shows how tobacco use impacts patients with kidney cancer

Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.

20 Oct 2020

Researchers explore new method to monitor the effectiveness of HIV treatment at home

Development of a new method to monitor the effectiveness of human immunodeficiency virus (HIV) treatment at home instead of in hospitals is underway by Penn State researchers.

20 Oct 2020

Scientists develop antibacterial nano-coatings based on boron nitride

NUST MISIS material scientists have presented antibacterial nano-coatings based on boron nitride, which are highly effective against microbial pathogens (up to 99.99%).

20 Oct 2020

Anti-inflammatory therapy helps slow progression of multiple sclerosis in a preclinical model

Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of multiple sclerosis, according to recent research out of the University of Alberta.

20 Oct 2020

Novel microfluidic approach to fight cancer could greatly benefit patients

CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technology to "purify" the immune cells of patients in the fight against cancer.

20 Oct 2020

Researchers develop a molecular docking based webserver to predict drug targets

A highly effective drug therapy is urgently required to combat coronavirus disease 2019 (COVID-19). The authors of this article have developed a molecular docking based webserver, namely D3Targets-2019-nCoV, with two functions, one is for predicting drug targets for drugs or active compounds observed from clinic or in vitro/in vivo studies, the other is for identifying lead compounds against potential drug targets via docking.

20 Oct 2020

Therapy News and Research

Monoclonal Antibodies: Discovery, Characterization and Challenges

Tumor DNA in spinal fluid can help track children with aggressive brain tumors

Newly developed light-sensing protein restores vision in blind mice

Study: Antibody-based drug could dramatically reduce cancer in mice

Studies examine impact of COVID-19 on neonatal intensive care units

Ancient elements in human DNA can activate powerful immune response to kill cancer cells

Tryptophan found in turkeys can accelerate intestinal healing in people with celiac disease

Moffitt researchers find immune-oncologic differences in prostate tumors of African American men

Scientists develop a way to accurately detect and monitor common pediatric brain cancer

Research shows the value of Multi-User Virtual Reality remote psychotherapy for eating disorders

Study characterizes biochemical mechanism of cancer-linked enzyme

Researchers receive more than $1 million NIH grants for COVID-19 pandemic-related projects

New DNA-cutting tool could advance gene editing for novel treatments

NIH awards $1.6 million for research on hormonal control of HIV latency

UC study shows how tobacco use impacts patients with kidney cancer

Researchers explore new method to monitor the effectiveness of HIV treatment at home

Scientists develop antibacterial nano-coatings based on boron nitride

Anti-inflammatory therapy helps slow progression of multiple sclerosis in a preclinical model

Novel microfluidic approach to fight cancer could greatly benefit patients

Researchers develop a molecular docking based webserver to predict drug targets

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News